CSO/CMO, INTERVENN BIOSCIENCES
South San Francisco, California, United States
Klaus Lindpaintner, MD, MPH, FACP, Chief Scientific and Medical Officer at InterVenn, previously held senior positions at Pfizer and at Hoffman-La Roche, spearheading the companies' efforts in personalized health care; as CSO at Thermo-Fisher-Scientific; and as faculty at Harvard University. He has co-authored some 250 scientific papers, holds honorary and adjunct professorships at several academic institutions and serves on numerous boards, working groups, and advisory panels for trade organizations, regulatory authorities, and non-governmental organizations on issues related to the successful implementation and leverage of novel technologies in health care. Klaus graduated from Innsbruck University with a degree in medicine, and from Harvard University with a degree in public health. He pursued post-graduate training and specialization in internal medicine, cardiology, and clinical and molecular genetics in the US and Germany and is a Diplomate of the Boards in these specialties.